Detailed information for compound 59228

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 585.778 | Formula: C32H51N5O5
  • H donors: 5 H acceptors: 5 LogP: 5.32 Rotable bonds: 21
    Rule of 5 violations (Lipinski): 2
  • SMILES: CC(C[C@H]([C@@H](CCCC(C)C)O)NC(=O)C(Cc1c[nH]cn1)NC(=O)C(Cc1ccccc1)NC(=O)OC(C)(C)C)C
  • InChi: 1S/C32H51N5O5/c1-21(2)12-11-15-28(38)25(16-22(3)4)35-30(40)27(18-24-19-33-20-34-24)36-29(39)26(17-23-13-9-8-10-14-23)37-31(41)42-32(5,6)7/h8-10,13-14,19-22,25-28,38H,11-12,15-18H2,1-7H3,(H,33,34)(H,35,40)(H,36,39)(H,37,41)/t25-,26?,27?,28-/m1/s1
  • InChiKey: WYTJYTNQWLQXNY-BDKHIZHFSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis phosphatidylinositol 4 phosphate 3 kinase C2 0.0253 0.0203 0.0203
Trichomonas vaginalis phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative 0.0253 0.0203 0.2209
Schistosoma mansoni cathepsin D (A01 family) 0.0174 0.0121 0.1309
Plasmodium falciparum phosphatidylinositol 3-kinase 0.0253 0.0203 1
Trichomonas vaginalis phosphatidylinositol 3-kinase catalytic subunit alpha, beta, delta, putative 0.0937 0.0921 1
Trichomonas vaginalis phosphatidylinositol kinase, putative 0.0253 0.0203 0.2209
Trichomonas vaginalis phopsphatidylinositol 3-kinase, drosophila, putative 0.0937 0.0921 1
Trichomonas vaginalis phosphatidylinositol 3-kinase class, putative 0.0253 0.0203 0.2209
Leishmania major phosphatidylinositol 4-kinase alpha, putative 0.0253 0.0203 0.5
Toxoplasma gondii phosphatidylinositol 3- and 4-kinase 0.0253 0.0203 0.3347
Echinococcus granulosus phosphatidylinositol 45 bisphosphate 3 kinase 0.0937 0.0921 0.0921
Giardia lamblia Phosphoinositide-3-kinase, catalytic, alpha polypeptide 0.0937 0.0921 0.5
Echinococcus granulosus phosphatidylinositol 3 kinase catalytic subunit 0.0253 0.0203 0.0203
Trypanosoma cruzi phosphatidylinositol 3-kinase 2, putative 0.0937 0.0921 1
Schistosoma mansoni phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K 0.0253 0.0203 0.2209
Trypanosoma cruzi phosphatidylinositol 4-kinase alpha, putative 0.0253 0.0203 0.0775
Entamoeba histolytica phosphatidylinositol 3-kinase, putative 0.0937 0.0921 1
Leishmania major phosphatidylinositol 3-kinase, putative 0.0253 0.0203 0.5
Trichomonas vaginalis phosphatidylinositol 3-kinase class, putative 0.0253 0.0203 0.2209
Brugia malayi Phosphatidylinositol 3- and 4-kinase family protein 0.0937 0.0921 1
Trypanosoma cruzi phosphatidylinositol 4-kinase alpha, putative 0.0253 0.0203 0.0775
Toxoplasma gondii PAN domain-containing protein 0.0638 0.0608 1
Loa Loa (eye worm) phosphatidylinositol 3 0.0195 0.0143 0.1554
Echinococcus multilocularis Zinc finger, PHD finger 0.0253 0.0203 0.0203
Mycobacterium tuberculosis Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) 0.9588 1 1
Trichomonas vaginalis phosphatidylinositol kinase, putative 0.0253 0.0203 0.2209
Entamoeba histolytica phosphatidylinositol 3-kinase 1, putative 0.0879 0.0861 0.916
Schistosoma mansoni phosphatidylinositol 4-kinase 0.0253 0.0203 0.2209
Trichomonas vaginalis phosphatidylinositol 4-kinase, putative 0.0253 0.0203 0.2209
Echinococcus granulosus phosphatidylinositol 4 kinase alpha 0.0253 0.0203 0.0203
Loa Loa (eye worm) hypothetical protein 0.0684 0.0656 0.7119
Echinococcus multilocularis thymidine phosphorylase 0.9588 1 1
Trypanosoma brucei phosphatidylinositol 4-kinase alpha, putative 0.0253 0.0203 0.5
Loa Loa (eye worm) hypothetical protein 0.0253 0.0203 0.2209
Plasmodium vivax phosphatidylinositol 3-kinase, putative 0.0253 0.0203 1
Entamoeba histolytica phosphatidylinositol 3-kinase, putative 0.0937 0.0921 1
Toxoplasma gondii PAN domain-containing protein 0.0638 0.0608 1
Trypanosoma brucei phosphatidylinositol 3-kinase, putative 0.0253 0.0203 0.5
Trichomonas vaginalis phosphatidylinositol 3-kinase catalytic subunit gamma, putative 0.0937 0.0921 1
Loa Loa (eye worm) phosphatidylinositol 4-kinase type 3 alpha isoform 1 0.0253 0.0203 0.2209
Echinococcus multilocularis phosphatidylinositol 4 kinase alpha 0.0253 0.0203 0.0203
Trypanosoma cruzi phosphatidylinositol 3-kinase 2, putative 0.0937 0.0921 1
Schistosoma mansoni phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K 0.0253 0.0203 0.2209
Echinococcus multilocularis phosphatidylinositol 4,5 bisphosphate 3 kinase 0.0937 0.0921 0.0921
Trypanosoma cruzi phosphatidylinositol 3-kinase vps34-like 0.0253 0.0203 0.0775
Echinococcus granulosus phosphatidylinositol 4 phosphate 3 kinase C2 0.0253 0.0203 0.0203
Schistosoma mansoni phosphatidylinositol-45-bisphosphate 3-kinase catalytic subunit alpha PI3K 0.0937 0.0921 1
Loa Loa (eye worm) phosphatidylinositol 3 0.0937 0.0921 1
Trichomonas vaginalis phosphatidylinositol 3-kinase class, putative 0.0937 0.0921 1
Toxoplasma gondii phosphatidylinositol 3- and 4-kinase 0.0253 0.0203 0.3347
Mycobacterium ulcerans thymidine phosphorylase 0.9588 1 1
Entamoeba histolytica hypothetical protein 0.0937 0.0921 1
Schistosoma mansoni cathepsin D (A01 family) 0.0174 0.0121 0.1309
Mycobacterium leprae Probable anthranilate phosphoribosyltransferase TrpD 0.2706 0.2778 0.5
Trichomonas vaginalis phosphatidylinositol kinase, putative 0.0937 0.0921 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.6 uM Inhibition of human renal renin at the pH optimum 6.0. ChEMBL. 3305946
Inhibition (binding) = 97 % Inhibition of human renal renin at the concentration of 10e-5 M. ChEMBL. 3305946

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.